Toripalimab Injection: Clinical Trials

5 trials of Toripalimab Injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 not yet recruiting, 1 withdrawn. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Recruiting 3, Not yet recruiting 1, Withdrawn 1

Follow Toripalimab Injection: new trials by email Literature Review of Toripalimab Injection trials Research Report on Toripalimab Injection

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Chiauranib, Toripalimab Injection, Albumin-paclitaxel Injection - Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3Not yet recruitingChipscreen Biosciences, Ltd.5582026-03-312026-03-03
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
SHR-A1811 for Injection, SHR-1316 Injection, Toripalimab Injection - PD-L1-positive Locally Recurrent Unresectable or Metastatic Triple-negative Breast Cancer
Phase 3RecruitingSuzhou Suncadia Biopharmaceuticals Co., Ltd.4002025-08-202025-12-18
9MW2821 in Combination With Toripalimab vs Standard Chemotherapy in Locally Advanced or Metastatic Urothelial Cancer
9MW2821, Toripalimab, Gemcitabine - Urothelial Carcinoma
Phase 3RecruitingMabwell (Shanghai) Bioscience Co., Ltd.4602024-08-222024-09-19
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Tifcemalimab injection, toripalimab injection, Placebo for Tifcemalimab - Limited-stage Small Cell Lung Cancer (LS-SCLC)
Phase 3RecruitingShanghai Junshi Bioscience Co., Ltd.7562023-11-152026-07-27
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Toripalimab Injection, Gemcitabine Hydrochloride for Injection, Cisplatin for Injection / Carboplatin Injection - Locally Advanced or Metastatic Urothelial Carcinoma
Phase 3WithdrawnShanghai Junshi Bioscience Co., Ltd.2022-09-062026-07-09

Conditions studied

Carcinoma, Transitional Cell (2)  ·  Small Cell Lung Carcinoma (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Shanghai Junshi Bioscience Co., Ltd. (2)  ·  Chipscreen Biosciences, Ltd. (1)  ·  Mabwell (Shanghai) Bioscience Co., Ltd. (1)  ·  Suzhou Suncadia Biopharmaceuticals Co., Ltd. (1)

Countries

China (5)  ·  Georgia (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 40288679